Skip to main content

Take advantage of the world's fastest growing clinical trials region

Talk to our experts about your Asia Pacific clinical research strategy

The Asia-Pacific CRO

A multi-award winning, leading regional contract research organization (CRO)

Headquartered in Australia since 1996 and operating in the Asia Pacific region, Novotech is internationally recognized in the industry as a leading regional full-service CRO.


Accelerate your clinical development program. From project management through to clinical trial monitoring, management and patient recruitment. We’re one of the Asia-Pacific’s leading contract research organizations (CROs), and we have been for nearly two decades. Learn more about what makes Novotech unique in the Asia-Pacific region

Delivering accurate, high-quality and timely biostatistics services, including statistical planning, analysis and reporting. And staffed by highly experienced in-house statisticians. Learn more...

Leveraging high-quality, cost-effective solutions to ensure successful management and delivery of clinical trial data. Services include a suite of industry gold standard EDC platforms with accredited in-house database builders.

Providing first-class regulatory services to help expedite drug development within a complex and dynamic environment. Speak to our dedicated regulatory and ethics applications team for insights into the challenges of the trial approval process. Learn more about our pharmaceutical regulatory affairs consulting.

Providing independent Quality Assurance services by highly experienced professionals, across all clinical trial phases. Learn more about our audits services...

Writing credible and high quality medical and scientific content to support your clinical development needs. Our medical writers have been hand-picked from life sciences backgrounds and all boast substantial regulatory experience within contract research organizations. Learn more about our medical writing services...

Our Asia Pacific Presence

300+ professionals
18 locations
11 countries
3.5 Billion population base

A World of Experience

When South Korean oncology biotechnology company PharmAbcine completed a successful domestic phase I study for the t

In support of a global registry study, the Thrombosis Research Institute (TRI) engaged Novotech to monitor a regist

News & Events

Latest News


The Indian CRO market has undoubtedly contracted over the last few years following activity after the 2012 Supreme Court petition by the...


Novotech has been awarded ‘Australian Exporter of The Year’ the 2017 Indian Australia Business Community (IABCA) Awards. 


Newsletter Subscription

Subscribe to our newsletter for regular updates about Novotech.